|
Putting Promotion in Perspective: Part I - A Strategic OverviewPublished by: Decision Resources Published: Jun. 30, 2005 - 21 Pages The price of this report has been reduced due to its age. The original price was $1,900 for PDF E-mail From Publisher.Table of Contents
AbstractPromotional expenditure is the principal area of cost for the pharmaceutical industry. Fully expressed, these costs far outweigh R&D expenditure, yet they tend to receive less attention from pharmaceutical and biotechnology companies than other cost areas and are prioritized far behind sales when companies gauge the factors that determine a product’s or project’s viability. In this report, the first of a two-part series, we present quantitative data to support a realistic perspective on promotional expenditure in the pharmaceutical industry, and we explore the implications that modifications of promotional spend would have for pharmaceutical and biotechnology companies. We explain how close attention to this critical area of cost can increase the accuracy of decision making regarding the commercial viability of products and suggest how the industry should view recent trends in promotional expenditure. We offer advice on how the role of promotion should be conveyed to those outside the industry.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||